The Growing Wave of Medical Device Lawsuits in Recent Years

Medical devices have genuinely changed what's possible in healthcare. Implants, ports, filters, and mesh products give physicians tools they didn't have a generation ago, and for millions of patients, those tools work exactly as intended. But when a device fails — when it fractures, migrates, erodes, or causes the kind of damage no one warned you about — the consequences don't end when the device is removed. Some of them follow patients for years. And increasingly, those patients are ending up in court.

The expanding role of medical technology is also reflected in the size of the industry itself. The global medical devices market is estimated at USD 735.12 billion in 2026 and is expected to reach USD 1,203.81 billion by 2033, exhibiting a CAGR of 7.3% from 2026 to 2033. As more patients rely on sophisticated devices for diagnosis, treatment, monitoring, and long-term care, the scale of the industry also creates a larger landscape in which device safety, post-market surveillance, and patient outcomes matter.

Lawsuits involving implanted medical products have risen steadily over the past decade, and the reasons aren't hard to find. More people are living with implanted devices for longer periods. Electronic health records preserve imaging, lab results, and operative notes in ways that paper files never did. And patient communities, many of them online, have made it easier for scattered individuals to recognize that their experience isn't unique. Claims tied to the Bard PowerPort recall are one example of exactly this pattern: reports of catheter fractures and device migration surfacing across facilities, individual injuries becoming visible as a collective problem. When one person's experience matches fifty others across thirty states, that pattern becomes the foundation of a legal claim.

When an Implanted Port Becomes the Subject of a Lawsuit

Implanted venous ports are among the more common devices drawing legal attention right now. Clinicians use them to deliver chemotherapy, antibiotics, blood products, and nutritional support over extended treatment courses, sparing patients the repeated needle sticks that fragile peripheral veins can't sustain. For a cancer patient in active treatment, a working port is a necessity.

Recent legal claims have centered on allegations that some port systems malfunctioned and caused serious harm. Plaintiffs have alleged that catheter fractures, device migration, and vessel injuries occurred at rates not adequately disclosed to surgeons or patients. These types of cases raise particular questions for the manufacturer: Was the material strong enough? Were post-market complaints taken seriously? Were surgeons warned clearly and in time? Did the labeling reflect what the company actually knew?

The answers come from documents, not memory. That's the nature of device litigation. The paper trail matters.

The range of medical devices involved also means that safety concerns can differ significantly depending on the type and risk level of the product. By device class, the medical devices market is segmented into Class I low-risk devices, Class II moderate-risk devices, and Class III high-risk devices. Class II devices are expected to account for approximately 56.3% of the market in 2026 and include products such as infusion pumps and surgical drapes. Class III devices include higher-risk products such as implantable pacemakers and heart valves, where performance, failure risks, and long-term safety can have particularly serious consequences for patients.

The Records That Drive These Cases

Device litigation lives and dies on documentation. Radiology images can show exactly where a catheter fragment ended up. Operative reports describe what the surgeon found during removal. Adverse event reports filed with the FDA may reveal that similar injuries were happening at other hospitals long before your surgery was scheduled.

Internal company files sometimes surface in discovery and tell an even more specific story. Emails between engineers and safety reviewers. Communications between sales staff and physicians. Records of what the company knew about failure rates, and when they knew it. Courts use this material not just to establish what happened to a specific patient, but to determine whether the manufacturer behaved responsibly across its entire product line.

For patients, the practical implication is straightforward. Start gathering your records now. Operative reports, implant cards, imaging studies, discharge summaries, notes from follow-up appointments — all of it matters. A case built on complete documentation is a stronger case. One built on gaps and missing records is harder to make.

The importance of documentation extends across a broad product landscape. By product type, the medical devices market includes diagnostic devices, therapeutic devices, surgical instruments and devices, minimally invasive surgical tools, monitoring devices, implantable devices, dental devices, patient aid and support devices, and other medical devices. Diagnostic devices alone are expected to contribute 24.4% of the market in 2026. That category includes in-vitro diagnostics, diagnostic imaging, and point-of-care testing, all of which generate records that can become relevant when investigating a patient's treatment history or an alleged device-related injury.

Why Warnings Are Central to Most Device Claims

Product liability cases involving medical devices rarely argue that the device should never have existed. More often, they argue that what happened to the patient could have been prevented with an honest warning. And that distinction matters, because it shifts the focus from the device itself to what surgeons and patients were told about it.

A genuinely useful warning tells physicians what can go wrong, how often it happens, which patients are at higher risk, and what symptoms should trigger urgent follow-up. Most patients don't read the technical insert before surgery. They rely on their surgeon, who relies on what the manufacturer put in the labeling. If a known risk was downplayed, disclosed only in technical language buried on page twelve, or left out entirely, then the informed consent process broke down somewhere in that chain.

Courts look at this carefully. They compare what the label said to what the company's internal records showed. They ask whether surgeons received updated warnings when new safety signals emerged. They examine whether patient materials reflected the same information given to physicians. When there's a gap between what was known and what was disclosed, that gap becomes the center of the case.

What a Recall Actually Means for Your Situation

This is where a lot of patients get confused, and it's worth being direct about it. A device recall doesn't always mean the product needs to come out immediately. Some recalls update labeling. Some modify distribution or sterilization procedures. Some address manufacturing process changes that don't affect devices already implanted. The word 'recall' can cover a wide range of actions, and the specifics matter enormously for individual patients.

If you've seen advertising about a recall and you have an implanted device, the right first step isn't to call a law firm. It's to find out exactly which product you have — the manufacturer, the model, the lot number — and ask your physician whether your specific device falls within the affected range and whether your current symptoms or imaging studies suggest any reason for concern. Legal options flow from medical clarity, not the other way around.

That said, if your physician confirms that your device is affected, that you've experienced complications that match the reported failure pattern, and that the device has been removed or needs to be, then the legal question becomes relevant.

For patients and manufacturers operating in the U.S. medical devices market, these issues also intersect with the country's regulatory, reporting, and product-liability environment. The specific legal implications of a recall can vary depending on the device, the nature of the defect, the applicable regulatory action, and the circumstances of the patient's injury.

The Bigger Picture for Patients

Medical device litigation has grown because modern healthcare has become more dependent on implanted technology, and because patients now have better tools to recognize when their experience isn't isolated. That growth has real consequences beyond individual courtrooms. It pressures manufacturers to invest more seriously in post-market surveillance. It creates incentives for earlier and clearer disclosure when safety signals emerge. It prompts hospitals to improve the way they track implant data and follow up with patients whose devices have been flagged.

The broader medical device industry is supported by major companies operating across diagnostics, implants, surgical technologies, monitoring, and other healthcare applications. Key players include Medtronic, Siemens Healthineers, Philips Healthcare, GE Healthcare, Johnson & Johnson, Stryker Corporation, Baxter International, Abbott Laboratories, Boston Scientific, Zimmer Biomet, Thermo Fisher Scientific, Cardinal Health, Edwards Lifesciences, Hologic, and Intuitive Surgical. Their presence across different device categories illustrates how diverse the market has become and why safety considerations can differ significantly between diagnostic, therapeutic, surgical, monitoring, and implantable technologies.

None of that makes the process easy for the individual patient going through it. These cases are slow, technical, and stressful. But for people who have lived with serious injuries from devices that were supposed to help them, the opportunity to hold a manufacturer accountable — and to make the outcome of their experience mean something for patients who come after them — is often what keeps them going.

If you're in that position, the most useful thing you can do right now is to understand exactly what device you have, get your medical records organized, and consult with a physician about whether your current situation warrants further evaluation. Legal decisions can come later. Medical clarity comes first, and everything useful flows from there.